Contingencies and commitments - Universal Cells Research, Collaboration and License Agreement and Co-development and Co-commercialization agreement (Details) - Collaboration and license agreement - Universal Cells, Inc. |
Dec. 31, 2022
USD ($)
|
|---|---|
| Contingencies and commitments | |
| First milestone payment | $ 500,000 |
| Second milestone payment | 600,000 |
| Third milestone payment | $ 400,000 |
| X | ||||||||||
- Definition The amount of milestone payment. No definition available.
|
| X | ||||||||||
- Definition The amount of milestone payment three. No definition available.
|
| X | ||||||||||
- Definition The amount of milestone payment two. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|